How to identify the asymptomatic high-risk patient?

Area of Science:

• Cardiology
• Preventive Medicine
• Medical Diagnostics

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death and illness.
• Current risk assessment methods often misclassify individuals, leaving high-risk asymptomatic patients undetected and intermediate-risk patients with uncertain management.
• There is a critical need for improved strategies to identify asymptomatic individuals at elevated CVD risk.

Purpose of the Study:

• To review current and emerging approaches for identifying asymptomatic individuals at elevated risk of cardiovascular disease events.
• To highlight the limitations of traditional risk assessment in accurately stratifying cardiovascular risk.
• To discuss the role of biomarkers and noninvasive imaging in refining cardiovascular risk prediction.

Main Methods:

• Literature review of studies on cardiovascular risk assessment.
• Analysis of diagnostic accuracy of biomarkers for cardiovascular disease.
• Evaluation of noninvasive imaging techniques in identifying subclinical atherosclerosis.

Main Results:

• Traditional risk scores often fail to identify a significant portion of high-risk asymptomatic individuals.
• Biomarkers and advanced imaging modalities show promise in detecting early signs of cardiovascular disease.
• These newer methods can potentially improve the stratification of cardiovascular risk, aiding in timely intervention.

Conclusions:

• Improved identification of high-risk asymptomatic individuals is essential for effective cardiovascular disease prevention.
• Biomarkers and noninvasive imaging represent valuable tools to enhance current cardiovascular risk assessment strategies.
• Further research and clinical integration of these advanced methods are needed to reduce cardiovascular morbidity and mortality.